A survey of proteins encoded by non-synonymous single nucleotide polymorphisms reveals a significant fraction with altered stability and activity.

On average, each human gene has approximately four SNPs (single nucleotide polymorphisms) in the coding region, half of which are nsSNPs (non-synonymous SNPs) or missense SNPs. Current attention is focused on those that are known to perturb function and are strongly linked to disease. However, the vast majority of SNPs have not been investigated for the possibility of causing disease. We set out to assess the fraction of nsSNPs that encode proteins that have altered stability and activity, for this class of variants would be candidates to perturb cellular function. We tested the thermostability and, where possible, the catalytic activity for the most common variant (wild-type) and minor variants (total of 46 SNPs) for 16 human enzymes for which the three-dimensional structures were known. There were significant differences in the stability of almost half of the variants (48%) compared with their wild-type counterparts. The catalytic efficiency of approx. 14 variants was significantly altered, including several variants of human PKM2 (pyruvate kinase muscle 2). Two PKM2 variants, S437Y and E28K, also exhibited changes in their allosteric regulation compared with the wild-type enzyme. The high proportion of nsSNPs that affect protein stability and function, albeit subtly, underscores the need for experimental analysis of the diverse human proteome.

[1]  Sean D. Mooney,et al.  MutDB services: interactive structural analysis of mutation data , 2005, Nucleic Acids Res..

[2]  Rafael Najmanovich,et al.  Structural and Chemical Profiling of the Human Cytosolic Sulfotransferases , 2007, PLoS biology.

[3]  T. Tanaka,et al.  The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters. , 1987, The Journal of biological chemistry.

[4]  U. Stenman,et al.  Potentially hallucinogenic 5‐hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues , 2005, Scandinavian journal of clinical and laboratory investigation.

[5]  A. Mesecar,et al.  Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. , 2005, Biochemistry.

[6]  J. Moult,et al.  Identification and analysis of deleterious human SNPs. , 2006, Journal of molecular biology.

[7]  L. Brooks,et al.  A DNA polymorphism discovery resource for research on human genetic variation. , 1998, Genome research.

[8]  D. Schaid,et al.  Human Hydroxysteroid Sulfotransferase SULT2B1 Pharmacogenomics: Gene Sequence Variation and Functional Genomics , 2007, Journal of Pharmacology and Experimental Therapeutics.

[9]  T. Tanaka,et al.  Multimolecular forms of pyruvate kinase from rat and other mammalian tissues. I. Electrophoretic studies. , 1972, Journal of biochemistry.

[10]  D A Agard,et al.  Kinetics versus thermodynamics in protein folding. , 1994, Biochemistry.

[11]  Alexander V. Diemand,et al.  The Swiss‐Prot variant page and the ModSNP database: A resource for sequence and structure information on human protein variants , 2004, Human mutation.

[12]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[13]  J. Rathmell,et al.  New roles for pyruvate kinase M2: working out the Warburg effect. , 2008, Trends in biochemical sciences.

[14]  François Taddei,et al.  Asymmetric segregation of protein aggregates is associated with cellular aging and rejuvenation , 2008, Proceedings of the National Academy of Sciences.

[15]  Dan S. Tawfik,et al.  Chaperonin overexpression promotes genetic variation and enzyme evolution , 2009, Nature.

[16]  H. Christofk,et al.  Pyruvate kinase M2 is a phosphotyrosine-binding protein , 2008, Nature.

[17]  R. Waring,et al.  Sulfotransferase inhibition: potential impact of diet and environmental chemicals on steroid metabolism and drug detoxification. , 2008, Current drug metabolism.

[18]  Yusuke Nakamura,et al.  JSNP: a database of common gene variations in the Japanese population , 2002, Nucleic Acids Res..

[19]  B. Matthews,et al.  Protein structural plasticity exemplified by insertion and deletion mutants in T4 lysozyme , 1996, Protein science : a publication of the Protein Society.

[20]  Jennifer L. Martin,et al.  Active Site Mutations and Substrate Inhibition in Human Sulfotransferase 1A1 and 1A3* , 2004, Journal of Biological Chemistry.

[21]  E. Brown,et al.  Probing the active site of YjeE: a vital Escherichia coli protein of unknown function. , 2004, The Biochemical journal.

[22]  Eran Halperin,et al.  Leveraging the HapMap correlation structure in association studies. , 2007, American journal of human genetics.

[23]  S. Nagar,et al.  Sulfotransferase (SULT) 1A1 Polymorphic Variants *1, *2, and *3 Are Associated with Altered Enzymatic Activity, Cellular Phenotype, and Protein Degradation , 2006, Molecular Pharmacology.

[24]  Stacie L. Bulfer,et al.  A coupled fluorescent assay for histone methyltransferases. , 2005, Analytical biochemistry.

[25]  N. Shen,et al.  Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis , 1999, Nature Genetics.

[26]  Masoud Vedadi,et al.  Screening for Ligands Using a Generic and High-Throughput Light-Scattering-Based Assay , 2006, Journal of biomolecular screening.

[27]  M. Vedadi,et al.  Application of High-Throughput Isothermal Denaturation to Assess Protein Stability and Screen for Ligands , 2008, Journal of biomolecular screening.

[28]  P. Hargrave,et al.  Rhodopsin C terminus, the site of mutations causing retinal disease, regulates trafficking by binding to ADP-ribosylation factor 4 (ARF4). , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Zwerschke,et al.  Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7 , 2001, Oncogene.

[30]  A. Fersht,et al.  Structural and energetic responses to cavity-creating mutations in hydrophobic cores: observation of a buried water molecule and the hydrophilic nature of such hydrophobic cavities. , 1996, Biochemistry.

[31]  Simon Kasif,et al.  topoSNP: a topographic database of non-synonymous single nucleotide polymorphisms with and without known disease association , 2004, Nucleic Acids Res..

[32]  Heng Li,et al.  Snap: an integrated SNP annotation platform , 2006, Nucleic Acids Res..

[33]  D. A. Fernández‐Velasco,et al.  Thermodynamic and kinetic characterization of a germ line human lambda6 light-chain protein: the relation between unfolding and fibrillogenesis. , 2009, Journal of molecular biology.

[34]  David Haussler,et al.  LS-SNP: large-scale annotation of coding non-synonymous SNPs based on multiple information sources , 2005, Bioinform..

[35]  Sungsam Gong,et al.  SNP@Domain: a web resource of single nucleotide polymorphisms (SNPs) within protein domain structures and sequences , 2006, Nucleic Acids Res..

[36]  C. Nusbaum,et al.  Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. , 1998, Science.

[37]  François Stricher,et al.  How Protein Stability and New Functions Trade Off , 2008, PLoS Comput. Biol..

[38]  K. Dill,et al.  Comprehensive analysis of protein folding activation thermodynamics reveals a universal behavior violated by kinetically stable proteases. , 2005, Journal of molecular biology.

[39]  Gudmundur A. Thorisson,et al.  The International HapMap Project Web site. , 2005, Genome research.

[40]  R. Freedland,et al.  Activation of pyruvate kinase by 6-phosphogluconate. , 1979, The Journal of biological chemistry.

[41]  B. Stoddard,et al.  The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate. , 1998, Structure.

[42]  J. Kelly,et al.  Backbone-Backbone H-Bonds Make Context-Dependent Contributions to Protein Folding Kinetics and Thermodynamics: Lessons from Amide-to-Ester Mutations. , 2005, Advances in protein chemistry.

[43]  Warren C. Lathe,et al.  Prediction of deleterious human alleles. , 2001, Human molecular genetics.

[44]  S. Cheng,et al.  An in vitro novel mechanism of regulating the activity of pyruvate kinase M2 by thyroid hormone and fructose 1, 6-bisphosphate. , 1991, Biochemistry.

[45]  C. Allis,et al.  Methylation of Histone H4 at Arginine 3 Facilitating Transcriptional Activation by Nuclear Hormone Receptor , 2001, Science.

[46]  E. Lander,et al.  Characterization of single-nucleotide polymorphisms in coding regions of human genes , 1999 .

[47]  P. Michels,et al.  Evolution of glycolysis. , 1993, Progress in biophysics and molecular biology.

[48]  François Stricher,et al.  SNPeffect: a database mapping molecular phenotypic effects of human non-synonymous coding SNPs , 2004, Nucleic Acids Res..

[49]  Peng Yue,et al.  SNPs3D: Candidate gene and SNP selection for association studies , 2006, BMC Bioinformatics.

[50]  E. Alexov,et al.  Approaches and resources for prediction of the effects of non-synonymous single nucleotide polymorphism on protein function and interactions. , 2008, Current pharmaceutical biotechnology.

[51]  C. Boschek,et al.  Pyruvate kinase type M2 and its role in tumor growth and spreading. , 2005, Seminars in cancer biology.

[52]  A. D. Rodrigues,et al.  Sulfotransferase 1E1 is a low km isoform mediating the 3-O-sulfation of ethinyl estradiol. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[53]  Ru Wei,et al.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.

[54]  J. Moult,et al.  SNPs, protein structure, and disease , 2001, Human mutation.

[55]  P. Nordlund,et al.  Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination , 2006, Proceedings of the National Academy of Sciences.

[56]  Yan P. Yuan,et al.  HGVbase: a human sequence variation database emphasizing data quality and a broad spectrum of data sources , 2002, Nucleic Acids Res..

[57]  D. Schaid,et al.  Genetic diversity and function in the human cytosolic sulfotransferases , 2007, The Pharmacogenomics Journal.

[58]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[59]  Pietro Liò,et al.  Prediction by Graph Theoretic Measures of Structural Effects in Proteins Arising from Non-Synonymous Single Nucleotide Polymorphisms , 2008, PLoS Comput. Biol..

[60]  Emil Alexov,et al.  Modeling effects of human single nucleotide polymorphisms on protein-protein interactions. , 2009, Biophysical journal.

[61]  R. Duggleby,et al.  Analysis of the substrate specificity of human sulfotransferases SULT1A1 and SULT1A3: site-directed mutagenesis and kinetic studies. , 1999, Biochemistry.

[62]  Eugene I. Shakhnovich,et al.  Protein stability imposes limits on organism complexity and speed of molecular evolution , 2007, Proceedings of the National Academy of Sciences.

[63]  W. Tan,et al.  A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking. , 2003, Carcinogenesis.

[64]  G. Senisterra,et al.  High throughput methods of assessing protein stability and aggregation. , 2009, Molecular bioSystems.

[65]  J. Moult,et al.  Loss of protein structure stability as a major causative factor in monogenic disease. , 2005, Journal of molecular biology.

[66]  Jennifer L. Martin,et al.  Human sulfotransferases and their role in chemical metabolism. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[67]  K. Lee,et al.  Theoretical studies of the response of a protein structure to cavity-creating mutations. , 2000, Biophysical journal.

[68]  Valentin A. Ilyin,et al.  Structure SNP (StSNP): a web server for mapping and modeling nsSNPs on protein structures with linkage to metabolic pathways , 2007, Nucleic Acids Res..

[69]  C. Rock,et al.  Crystal Structures of Human Pantothenate Kinases , 2007, Journal of Biological Chemistry.

[70]  R. Weinshilboum,et al.  Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. , 2004, Biochemical and biophysical research communications.

[71]  T. Tanaka,et al.  The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. , 1986, The Journal of biological chemistry.

[72]  Wen-Hsiung Li,et al.  Low nucleotide diversity in man. , 1991, Genetics.

[73]  R. Sobti,et al.  Impact of polymorphism in sulfotransferase gene on the risk of lung cancer. , 2006, Cancer genetics and cytogenetics.